Industries

The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transformation, RTLS is increasingly being deployed as an...

The global healthcare cloud market is expanding as healthcare organizations move beyond early cloud adoption and begin to use cloud environments as a foundation for managing data, enabling interoperability, and supporting more integrated clinical and operational workflows. As adoption matures, cloud is increasingly being positioned not just as infr...

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring platforms by original equipment manufacturers (OEM...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilit...

The global healthcare cybersecurity market is entering a new phase of growth as cyber risk becomes directly linked to patient safety, care continuity, and operational resilience. Healthcare organizations are expanding digital infrastructure across cloud environments, connected medical devices, patient-facing applications, and interoperable care eco...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.

These disruptions continue t...

The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions.

Leading players in the global life sciences LIMS market, including LabWare, Benchling, Clinisys...

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...